Antimicrobial Polymer for Ophthalmic Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ophthalmic implant devices face significant challenges in preventing microbial infections, as existing strategies such as topical antibiotics and surface-coated antibacterial agents are either non-compliant or lose their effectiveness over time, while infusing metal ions can cause toxicity and leaching issues.
Innovation Solution
Development of antimicrobial polymers obtained by copolymerizing antimicrobial monomers with acrylic, silicone, or collagen monomers, which are biocompatible, reversibly deformable, and provide comprehensive antimicrobial properties throughout the implant, ensuring continued infection prevention even if the surface erodes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If topical antibiotic drops are used to prevent infection, then infection risk is reduced, but patient compliance is required for proper dosing
Solution Approach 1:
The implant device incorporates antimicrobial monomers that provide self-service infection prevention functionality. The device itself produces the antimicrobial effect through its inherent composition, eliminating the need for external antibiotic administration and patient compliance.
2Reliability
If antibacterial chemicals are coated or covalently bonded to the implant surface, then infection risk is reduced, but the coating erodes over time reducing effectiveness
Solution Approach 1:
The invention changes the fundamental parameter of antimicrobial agent integration from surface-level coating to bulk polymer incorporation. The antimicrobial monomers are copolymerized into the implant's molecular structure, transforming the delivery mechanism from external coating to intrinsic material property, thereby ensuring long-term durability without erosion.
3Reliability
If metal ions are infused into the polymer, then antimicrobial properties are provided, but toxicity and leaching issues occur
Solution Approach 1:
The invention changes the chemical composition parameter from metal ions to organic antimicrobial monomers. This substitution eliminates the toxicity and leaching problems associated with metal ions while maintaining effective antimicrobial activity through the copolymerized organic structures.
4Reliability
If free metal ions are used as antibacterial agents, then antimicrobial effect is achieved, but the polymer loses properties over time due to leaching
Solution Approach 1:
The invention changes the delivery mechanism parameter from free ion diffusion to copolymerized structural integration. The antimicrobial monomers are permanently incorporated into the polymer chains, preventing leaching and ensuring sustained antimicrobial effectiveness throughout the implant's service life.
Data Source
AI summary
An antimicrobial polymer for use in an ophthalmic implant, includes at least one antimicrobial monomer; and at least one other monomer selected from an acrylic, silicone, vinyl and collagen monomer.